Group 1 - The core point of the article highlights the recent trading activity of southbound funds in relation to Jinxin Reproductive Medicine (01951.HK), indicating a reduction of 626,000 shares on February 27, while there were two days of net increases totaling 4.5723 million shares over the last five trading days [1] - Over the past 20 trading days, Jinxin Reproductive Medicine experienced net increases in southbound funds for 12 days, accumulating a total of 9.4858 million shares [1] - As of now, southbound funds hold 1.463 billion shares of Jinxin Reproductive Medicine, representing 53.03% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [1] - The company's services are mainly provided in China and the United States [1]

Group 1 - The core point of the article highlights that southbound funds increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 2.727 million shares on February 13, 2026, while experiencing a net reduction of 13.909 million shares over the past five trading days [1] - Over the last 20 trading days, southbound funds have increased their holdings in Jinxin Reproductive Medicine on 15 occasions, resulting in a total net increase of 24.1786 million shares [1] - As of now, southbound funds hold 1.461 billion shares of Jinxin Reproductive Medicine, accounting for 52.97% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [2] - The company's services are mainly provided in China and the United States [2]

Group 1 - The core point of the article highlights that southbound funds reduced their holdings in Jinxin Reproductive Medicine (01951.HK) by 4.8555 million shares on February 11, with a total net reduction of 5.5385 million shares over the last five trading days [1] - Over the past 20 trading days, southbound funds increased their holdings on 14 days, resulting in a cumulative net increase of 19.0741 million shares [1] - As of now, southbound funds hold 1.466 billion shares of Jinxin Reproductive Medicine, accounting for 53.15% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, ambulatory surgical center facility services, auxiliary medical services, and maternal and pediatric medical services, as well as the sale of medical consumables and equipment [1] - The company primarily operates in China and the United States [1]

Core Viewpoint - Southbound funds have increased their holdings in Jinxin Fertility (01951.HK), indicating growing investor interest in the company and its services in the assisted reproductive sector [1] Group 1: Shareholding Activity - On February 10, southbound funds increased their holdings by 679,000 shares of Jinxin Fertility [1] - Over the past five trading days, there have been four days of net increases in holdings, totaling 3.4365 million shares [1] - In the last 20 trading days, there were 14 days of net increases, amounting to 20.0356 million shares [1] - Currently, southbound funds hold 1.471 billion shares of Jinxin Fertility, representing 53.33% of the company's issued ordinary shares [1] Group 2: Company Overview - Jinxin Fertility Medical Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, and obstetrics and pediatrics medical services [1] - Jinxin Fertility operates mainly in China and the United States, also engaging in the sale of medical consumables and equipment [1]

Group 1 - Southbound funds reduced their holdings in Jinxin Fertility (01951.HK) by 4.7445 million shares on February 9 [1] - Over the past 5 trading days, southbound funds increased their holdings on 4 days, with a total net increase of 13.3475 million shares [1] - In the last 20 trading days, there were 13 days of net increases in holdings by southbound funds, totaling 13.3616 million shares [1] - Currently, southbound funds hold 1.47 billion shares of Jinxin Fertility, accounting for 53.31% of the company's issued ordinary shares [1] Group 2 - Jinxin Fertility Medical Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as sales of medical consumables and equipment [1] - The company primarily operates in China and the United States [1]

Group 1 - The core point of the article highlights that southbound funds have increased their holdings in Jinxin Reproductive Medicine (01951.HK) by 2.947 million shares on February 5, with a total net increase of 17.619 million shares over the last five trading days [1] - Over the past 20 trading days, southbound funds have increased their holdings on 13 days, resulting in a cumulative net increase of 16.8501 million shares [1] - As of now, southbound funds hold 1.474 billion shares of Jinxin Reproductive Medicine, accounting for 53.45% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [1] - The company's services are mainly provided in China and the United States [1]

Group 1 - The core viewpoint of the article highlights the significant increase in southbound capital holdings in Jinxin Reproductive Medicine (01951.HK), with a net increase of 1,745,250 shares over the last five trading days [1] - Over the past 20 trading days, there have been 11 days of net reductions in southbound capital holdings, totaling a decrease of 13,433,500 shares [1] - As of now, southbound capital holds 1.454 billion shares of Jinxin Reproductive Medicine, accounting for 52.73% of the company's total issued ordinary shares [1] Group 2 - Jinxin Reproductive Medicine Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers a range of services through its subsidiaries, including assisted reproductive services, management services, ambulatory surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as the sale of medical consumables and equipment [1] - The company's services are mainly provided in China and the United States [1]

Group 1 - Southbound funds increased their holdings in Jinxin Fertility (01951.HK) by 5.839 million shares on January 22 [1] - Over the past five trading days, southbound funds have increased their holdings for four days, with a total net increase of 9.23 million shares [1] - In the last 20 trading days, there were 11 days of net reductions by southbound funds, totaling 9.282 million shares [1] Group 2 - As of now, southbound funds hold 1.453 billion shares of Jinxin Fertility, accounting for 52.69% of the company's issued ordinary shares [1] - Jinxin Fertility Medical Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as sales of medical consumables and equipment, mainly in China and the United States [1]

Group 1 - Southbound funds increased their holdings in Jinxin Fertility (01951.HK) by 4.042 million shares on January 20 [1] - Over the past 5 trading days, there were 3 days of net reductions by southbound funds, totaling a net decrease of 7.806 million shares [1] - In the last 20 trading days, there were 12 days of net reductions by southbound funds, with a cumulative net decrease of 23.608 million shares [1] Group 2 - As of now, southbound funds hold 1.443 billion shares of Jinxin Fertility, accounting for 52.31% of the company's issued ordinary shares [1] - Jinxin Fertility Medical Group Co., Ltd. is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as sales of medical consumables and equipment, mainly in China and the United States [1]

Group 1 - Southbound funds increased their holdings in Jinxin Fertility (01951.HK) by 2.1385 million shares on January 19 [1] - Over the past 5 trading days, southbound funds have reduced their holdings on 4 days, with a total net reduction of 17.843 million shares [1] - In the last 20 trading days, there were 13 days of net reductions by southbound funds, totaling 28.1335 million shares [1] Group 2 - As of now, southbound funds hold 1.439 billion shares of Jinxin Fertility, accounting for 52.17% of the company's issued ordinary shares [1] - Jinxin Fertility Medical Group Limited is an investment holding company primarily providing in vitro fertilization (IVF) services [1] - The company offers assisted reproductive services, management services, mobile surgical center facility services, auxiliary medical services, obstetrics and pediatrics medical services, as well as sales of medical consumables and equipment, mainly in China and the United States [1]